Seok-Gu Kang

44PUBLICATIONS
108CO-AUTHORS
NanomaterialsNeurogeneticsMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Sep 03, 2026
NatD promotes glioblastoma progression through epigenetic activation of FGFR4 signalling.

|Aug 07, 2026
Putative glioblastoma origin-like cells in the subventricular zone: isolation and characterization.

|Mar 20, 2026
Beyond the Tumor Mass: From Initiating Clones to Overt Isocitrate Dehydrogenase-Mutant Gliomas.

Jung Won Park, Jeong Ho Lee, Seok-Gu Kang

|Jan 08, 2026
IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation.

Jung Won Park, Jiehoon Kwak, Keon-Woo Kim

|Jan 03, 2026
Pharmacological transglutaminase 2 inhibition enhances temozolomide response in patient-derived glioblastoma tumorspheres.

Jun Pyo Hong, Je Beom Hong, Byungho Lee

|Dec 06, 2025
Restoring the glioblastoma tumor microenvironment by targeting C5a with the antagonist W54011.

Yoojung Oh, Jihwan Yoo, Dongkyu Lee

Pageof 8

Frequent Collaborators

25 joint publications

Jong-Hee Chang

16 joint publications

Tae-Shin Kim

13 joint publications

Se Hoon Kim

11 joint publications

Su-Hyung Park